Search clinical trials for: Metastatic Castrate-Resistant Prostate Cancer (mCRPC),
Total 88826 results
-
POINT Biopharma, a wholly owned subsidiary of Eli...Eli Lilly and CompanyRecruitingProstate Cancer | Biochemically Recurrent Prostate Carcinoma | Metastatic Castration-resistant Prostate CancerCanada
-
Lantheus Medical ImagingPOINT BiopharmaAvailableCastration-Resistant Prostatic CancerUnited States
-
Radboud University Medical CenterVGZ health insurance (NL); Paul Speth Foundation (NL); Radboud Oncology Fund...RecruitingMetastatic Prostate CancerNetherlands
-
PfizerAstellas Pharma IncActive, not recruitingmCRPCChina, Finland, Spain, United States, Hungary, Israel, Belgium, Korea, Republic of, France, Canada, Czechia, Australia, Japan, Brazil, Germany, Argentina, New Zealand, United Kingdom, Norway, South Africa, Poland, Portugal, Chile, Italy, Pe... and more
-
Impact Therapeutics, Inc.Not yet recruitingmCRPCAustralia, United States, China
-
AstraZenecaCompleted
-
Tianjin Medical University Second HospitalThe Second Hospital of Hebei Medical University; Tianjin Medical University... and other collaboratorsCompleted
-
Istituto Scientifico Romagnolo per lo Studio e...RecruitingProstate-specific Membrane Antigen | mCRPC or Advanced/Metastatic Solid TumorsItaly
-
BayerRecruitingAdvanced Metastatic Castration-resistant Prostate Cancer | Prostate Specific Membrane Antigen (PSMA) ExpressionCanada, United Kingdom, Belgium
-
Jiangxi Qingfeng Pharmaceutical Co. Ltd.UnknownMetastatic Castration Resistant Prostate Cancer
-
Peking Union Medical College HospitalRecruitingMetastatic Castration-resistant Prostate CancerChina
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...CompletedMetastatic Castration-resistant Prostate CancerChina
-
Fudan UniversityUnknownProstate Cancer MetastaticChina
-
University of PennsylvaniaProstate Cancer FoundationRecruiting
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityAstraZenecaRecruitingProstate Cancer | Prostate Carcinoma | Metastatic Castration-resistant Prostate CancerChina
-
Karolinska InstitutetThe Swedish Research Council; AstraZeneca; Janssen Pharmaceutica N.V., Belgium; Kom Op Tegen Kanker and other collaboratorsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Sweden, Belgium, Switzerland, Norway
-
MANA RBMBayer; Tulane University; Barbara Ann Karmanos Cancer Institute; Carolina Urologic...TerminatedMetastatic Castration-resistant Prostate CancerUnited States
-
Zenith EpigeneticsEnrolling by invitation
-
BayerCompletedProstatic Neoplasms, Castration-ResistantGermany
-
University Health Network, TorontoBayerActive, not recruitingMetastatic Prostate CancerCanada
-
Yinghao SunNot yet recruitingCastration-Resistant Prostatic Cancer
-
Sun Yat-sen UniversityNot yet recruitingMetastatic Prostate CancerChina
-
Xinhua Hospital, Shanghai Jiao Tong University...UnknownMetastatic Castration-resistant Prostate Cancer
-
Arvinas Androgen Receptor, Inc.Active, not recruitingProstate Cancer MetastaticUnited States
-
SCRI Development Innovations, LLCNovartisWithdrawnAdvanced Prostate CancerUnited States
-
Arvinas Androgen Receptor, Inc.RecruitingProstate Cancer MetastaticUnited States
-
Arvinas Androgen Receptor, Inc.Active, not recruitingProstate Cancer MetastaticCanada, United States, France, United Kingdom
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States, Italy, Spain, Belgium, Canada, France, Korea, Republic of, United Kingdom, Brazil, Czechia, Turkey, Australia, Chile, Germany, Japan, Netherlands, Slovakia
-
Eli Lilly and CompanyActive, not recruitingProstate CancerUnited States, China, Australia, Japan, Spain, Korea, Republic of, Netherlands, Denmark, Germany, France, Romania
-
Innocrin PharmaceuticalProstate Cancer Foundation; Prostate Cancer Clinical Trials ConsortiumCompleted
-
British Columbia Cancer AgencyCompletedMetastatic Castration-Resistant Prostate CancerCanada
-
Janssen Research & Development, LLCRecruitingProstatic NeoplasmsUnited States, France, Spain, Netherlands
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingMetastatic Castration-resistant Prostate CancerChina
-
Innocrin PharmaceuticalNational Cancer Institute (NCI)Completed
-
Zenith EpigeneticsAstellas Pharma Inc; Newsoara Biopharma Co., Ltd.RecruitingMetastatic Castration-Resistant Prostate CancerUnited States, China
-
Herlev and Gentofte HospitalBristol-Myers SquibbRecruitingProstate Cancer Metastatic | Metastatic Castration-resistant Prostate Cancer | Castrate Resistant Prostate Cancer | Prostate Cancer Stage IVDenmark
-
Dana-Farber Cancer InstituteEli Lilly and Company; Genentech, Inc.Active, not recruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Radboud University Medical CenterBristol-Myers SquibbActive, not recruitingProstatic Neoplasms, Castration-ResistantNetherlands
-
BayerCompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)United States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Epizyme, Inc.; PfizerActive, not recruitingMetastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
University Health Network, TorontoProstate Cancer CanadaCompleted
-
BayerCompletedMetastatic Castration Resistant Prostate Cancer (mCRPC)United States
-
Jiangsu HengRui Medicine Co., Ltd.CompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)China
-
Suzhou Kintor Pharmaceutical Inc,CompletedMetastatic Castrate Resistant Prostate Cancer (mCRPC)United States
-
Memorial Sloan Kettering Cancer CenterProgenics Pharmaceuticals, Inc.CompletedProstate Cancer | Metastatic Castration-Resistant Prostate Cancer (mCRPC)United States
-
Fusion Pharmaceuticals Inc.RecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Janssen Research & Development, LLCActive, not recruitingNeoplasmsCanada, Israel, Spain
-
University of California, San FranciscoAmerican Association for Cancer ResearchCompleted
-
Cougar Biotechnology, Inc.CompletedProstate Cancer | Prostate NeoplasmsUnited States